Term Name: prasugrel hydrochloride
Synonyms: (+-)-prasugrel hydrochloride, (RS)-prasugrel hydrochloride, 5-((1RS)-2-Cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl)-4,5,6,7-tetrahydrothieno(3,2-c)pyridin-2-yl acetate hydrochloride, Effient, LY 640315, LY640315, rac-2-(acetyloxy)-5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-5-ium chloride, rac-5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetate hydrochloride, rac-prasugrel hydrochloride, racemic prasugrel hydrochloride
Definition: A racemate comprising equal amounts of (R)- and (S)-prasugrel hydrochloride. Used to prevent blood clots in people with acute coronary syndrome who are undergoing a procedure after a recent heart attack or stroke, and in people with certain disorders of the heart or blood vessels.
Ontology: ChEBI [CHEBI:87697]  ( EBI )

Relationships
is a type of: racemate
has_part: (R)-prasugrel hydrochloride (S)-prasugrel hydrochloride
has_role: cardiovascular drug P2Y12 receptor antagonist platelet glycoprotein-IIb/IIIa receptor antagonist